Chordate Medical Holding Investor Relations Material
Latest events
Q3 2024
Chordate Medical Holding
Q1 2025
23 May, 2025
Q4 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Chordate Medical Holding
Access all reports
Chordate Medical Holding AB is a medical technology company that has developed and patented Ozilia Migraine (formerly K.O.S), a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The company focuses on providing solutions for patients suffering from chronic nasal congestion and chronic migraine, aiming to offer effective and non-pharmacological treatment options. The company is headquartered in Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CMH
Country
🇸🇪 Sweden